Navigation Links
Medical Industry Offers Food Ingredient Companies More Than One Billion Reasons to Think Healthy
Date:12/5/2007

NEW YORK, Dec. 5 /PRNewswire/ -- Growing price competition from low-cost manufacturers has been forcing ingredient companies to search for new ways to sustain profitable growth, which Kalorama Information predicts will likely come from the sale of products or byproducts to pharmaceutical, medical foods, or biomedical device companies -- a potential $1 billion market -- in a new report, Healthcare Opportunities for Food Ingredient Manufacturers.

Thousands of bioactive phytochemicals have potential or established pharmaceutical or medicinal applications. Food-grade pectin, used as a thickening agent and stabilizer in food, tops the industry's list of ingredients most likely to succeed in healthcare. Useful for such applications as drug delivery, gene repair, and tissue repair, pectin offers food ingredient manufacturers as much as $890 million in sales to the healthcare industry. Glycomacropeptide, a whey component that is released during the manufacture of cheese, has been shown to stimulate the body's synthesis and release of cholesystokinen. This compound plays a role in the regulation of digestion and appetite suppression, providing yet another $65.6 million market in the healthcare industry.

"There are a variety of market opportunities in the healthcare sector, either in drugs, medical foods, or medical devices," said Steven Heffner, publisher of Kalorama Information. "The cost-effective discovery and recovery of novel ingredients with improved properties from food processing streams depends on next generation analysis, isolation, and separation technologies. Food ingredient manufacturers will have to turn to science and technological advances to add value to their primary, byproduct, and waste streams."

Healthcare Opportunities for Food Ingredient Manufacturers analyzes the current and potential healthcare-related markets for some traditional food ingredients and materials, including glycomacropeptide, lactoferrin, dairy bioactives, serum protein concentrate, shell eggs, peanut skins, pectin, xanthan gum, and hydrogels. This report reviews the nature and direction of research, analyzes market opportunities for these materials in the pharmaceutical, medical foods, and biomedical device sectors, and provides an outlook on future markets. This report can be purchased directly from Kalorama Information by visiting http://www.kaloramainformation.com/Healthcare-Opportunities-Food-1468551. It is also available at MarketResearch.com.

About Kalorama Information

Kalorama Information supplies the latest in independent market research on medical markets. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit http://www.KaloramaInformation.com.

Contact:

Tom Ehart

MarketResearch.com

240-747-3014

tehart@marketresearch.com


'/>"/>
SOURCE Kalorama Information
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: ... events will interrelate. “End Time GPS” is the creation of published author, Wesley ... while working on military munitions and space-vehicle projects. Now, at age ninety-one, he shares ...
(Date:3/23/2017)... Seattle, WA (PRWEB) , ... March 23, 2017 , ... ... emergency and now estimates that there could be four million Zika-related cases in the ... to date with numbers of US cases reported per year skyrocketing to an estimated ...
(Date:3/23/2017)... Braunfels, TX (PRWEB) , ... March 23, 2017 , ... ... new clinic, located at 960 Gruene Road in Building 2. The clinic is the ... Dr. Andrew Bennett, PT, says opening the company’s second New Braunfels location brings things ...
(Date:3/23/2017)... ... ... are unaware of the dangers that infectious bacteria play in mouth disease, while 1 out ... that dentists recommend. The ramifications of improper oral upkeep go far beyond bad breath and ... hours of work each year due to dental issues. That is why Mediaplanet is proud ...
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company announced today ... accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary ... have excellent programs for the delivery and improvement of disease management and that ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Research and Markets has announced the addition of the ... ... oxygen therapy devices market to grow at a CAGR of 10.16% ... Therapy Devices Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:3/23/2017)... A research report by Mordor Intelligence ... reach USD 7.2 billion by the end of 2021 and ... procedure in which a sample is preserved prior to its ... since the methods are often allowing repeated testing. The report ... shared procedures in the lab. In many life science labs, ...
(Date:3/23/2017)... BOSTON , March 23, 2017 ... respond optimally to most vaccines because their young ... researchers at Boston Children,s Hospital report achieving strong ... the final preclinical model before human trials — ... the immune response. In two simultaneous papers, they ...
Breaking Medicine Technology: